INTRODUCTION
Allergic sensitization is a multistep process whereby presentation of environmental antigens (allergens) to the immune system results in the preferential activation of T helper (Th)-2 cells, i.e. T cells that are programmed to express IL-4, IL-13 and IL-5 upon activation. These cytokines in turn induce IgE as well as several if not all of the other cardinal features of Th2-dependent disorders, first and foremost bronchial hyper-responsiveness and eosinophilia.
It is becoming increasingly clear that allergic sensitization is strongly influenced by complex gene-by-environ-ment interactions. Indeed, environmental factors have been linked to the striking increase in IgE-mediated diseases (allergy, asthma, eczema) that has occurred over the last few decades (reviewed by von Mutius 1 ). Interestingly, this increase is most prevalent in industrialized, westernized countries and/or parallels the development of westernized life-styles. Thus, the incidence of allergic sensitization in children is 29% in Australia, and only 9% in Guinea Bissau. Furthermore, 37% of the population in the former West Germany is atopic, as compared to 8% in the former East Germany (reviewed by Wold 2 ). The connection between allergic sensitization and life-style has been rationalized in the hygiene hypothesis, 3 according to which increased hygiene and cleanliness and/or the wide-spread use of antibiotics and immunizations may have deprived the developing immune system of environmental cues shaped by evolution to skew adaptive immunity away from Th2 responses.
Because every individual in the population is exposed to allergens, but only some individuals become sensitized to them, the genetic background of the individual appears to be essential in determining allergic sensitization and its Total IgE levels are known to be under genetic control. Linkage studies have indicated that one or more loci on chromosome 5q may control total IgE, as well as asthma and bronchial hyperresponsiveness to non-specific stimuli. Our group has undertaken a systematic analysis of chromosome 5q, and has recently characterized five single nucleotide polymorphisms at position -1619, -1359, -1145, -809, and -159 in the promoter of the gene encoding CD14, the myeloid pattern recognition receptor that is critical for efficient innate immune responses to lipopolysaccharide and bacterial ligands. Individuals homozygous for the three major CD14 haplotypes found in the Children Respiratory Study population (n = 390) were analyzed for serum levels of total IgE and soluble CD14. A strong inverse correlation was found between these two parameters, i.e. carriers of the -1359T/-1145A/-159C haplotype had the highest levels of IgE, and the lowest levels of sCD14. Conversely, carriers of the -1359G/-1145G/-159T haplotype had the highest levels of sCD14 and the lowest IgE values. Our results suggest that genetic variation in CD14, a key gene of innate immunity, may modulate the effects that exposure to bacterial ligands has on the development of Th2 responses. clinical outcome. Significant familial correlation coefficients for IgE levels can be found between mother and offspring, father and offspring, and between siblings. Perhaps even more importantly, linkage studies have indicated that one or more loci on chromosome 5q may control total IgE, as well as asthma and bronchial hyperresponsiveness to non-specific stimuli. 4 Several genes on chromosome 5q have been explored for genetic variants associated with total serum IgE and other IgErelated phenotypes. Our group has undertaken a systematic analysis of chromosome 5q and has initially characterized a C→T single nucleotide polymorphism (SNP) at position -159 in the promoter of the gene encoding CD14. 5 More recently, we have identified four additional SNPs within 2 kb of the CD14 transcription start sites, at position -1619, -1359, -1145 and -809. CD14 is a pattern recognition receptor that mediates efficient responses to bacterial endotoxin, and exists as a membrane-bound and a soluble protein. Soluble CD14 (sCD14) is present in the serum in microgram amounts, and confers endotoxin responsiveness to CD14-negative cells. 6 We show here that a strong correlation exists between CD14 haplotypes, sCD14 serum levels, and total IgE.
PATIENTS AND METHODS
The population enrolled in the Tucson Children's Respiratory Study (CRS) was described previously. 5 The population is unselected, longitudinal and studied here with data sampling from age 11 years. The identification of the novel CD14 promoter SNPs, and the analysis of CD14 genotypes, are described in detail elsewhere (Baldini et al., manuscript in preparation) . Total serum IgE levels were measured by the paper radioimmunosorbent test (Pharmacia Diagnostic, Piscataway, NJ, USA). sCD14 was measured by ELISA (R&D Systems, Minneapolis, MN, USA). Differences between groups were assessed by one-way analysis of variance using SPSS.
RESULTS
A population from the Tucson CRS (n = 390, age 11 years) was genotyped for -1359G→T, -1145G→A and -159C→T. Positions -1359, -1145 and -159 were found to be in extremely tight linkage disequilibrium, so that virtually only three major haplotypes were found among homozygotes in the CRS population. Seventy-five individuals carried the most common haplotype (-1359G/-1145G/-159T), whereas 27 subjects were -1359T/-1145A/-159C, and 25 were -1359G/-1145A/-159C. Functional studies are currently ongoing to determine whether other combinations of CD14 alleles may not be permitted because of their impact on the regulation of CD14 expression. Figure 1 shows that there was a statistically significant difference between serum levels of sCD14 (P = 0.03) and total IgE (P = 0.01) among homozygotes for the three major CD14 haplotypes. Indeed, carriers of the -1359T/-1145A/-159C haplotype had the highest levels of IgE, and the lowest levels of sCD14. Conversely, carriers of the -1359G/-1145G/-159T haplotype had the highest levels of sCD14 and the lowest IgE values. Thus sCD14 and IgE appeared to be inversely related.
DISCUSSION
Innate immunity involves a set of pattern recognition receptors that identify invariant pathogen-associated molecular patterns (PAMPs; reviewed by Medzhitov et al. 7 and Hoffmann et al. 8 ). Pattern recognition receptors are exemplified by CD14, a molecule expressed on, and secreted by, myeloid cells. CD14-negative cells, such as epithelial and endothelial cells, become responsive to PAMPs in the presence of sCD14. 6 Membrane-bound and sCD14 bind a variety of PAMPs, e.g. lipopolysaccharide (LPS)/endotoxin from Gram-negative bacteria, lipoteichoic acids from Gram-positive bacteria, mycobacterial glycolipids, and mannans from yeasts. 9 Responses of inflammatory cells to subpicomolar concentrations of PAMPs require LPS-binding protein (LBP), a lipid transfer protein that recognizes the lipid A moiety of LPS and facilitates the binding of LPS to sCD14 or membrane CD14. 6 Our results show that significant differences in serum levels of sCD14 were detected among homozygotes for the three major CD14 haplotypes. Functional studies are currently on-going to test the biological relevance of these differences. We are particularly interested in determining whether CD14 haplotype-related variations exist in the amounts of sCD14 found in human breast milk. 10 Because allergy and asthma are thought to have their roots in early life, 11 genetically determined differences in the availability of milk sCD14 may represent an important mechanism to shape the interface between innate and adaptive immunity at a critical developmental stage.
The inverse association between levels of sCD14 and IgE among CD14 haplotypes found in our studies raises the possibility that exposure to bacterial products, such as LPS, may modulate IgE regulation, possibly by activating innate immune pathways that promote Th1 differentiation and/or modified Th2 responses. 12 This hypothesis is supported by recent findings that children raised in rural areas and heavily exposed to animals and LPS have a remarkably lower prevalence of allergy and asthma compared with children living in the same areas but not exposed to animals. 13 Furthermore, in a recent study the homes of allergen-sensitized infants were found to contain significantly lower concentrations of house-dust endotoxin than those of non-sensitized infants. Increased house-dust endotoxin concentrations correlated with increased proportions of interferon-γ-producing CD4 T cells. 14 If exposure to bacterial products can influence allergic sensitization, it is conceivable that genetic factors that modify LPS responsiveness may also influence susceptibility to the development of allergy and/or asthma. Interestingly, exposure to LPS may increase the severity of the disease in individuals with established asthma. 15 Also, allergen provocation augments endotoxin-induced nasal inflammation in subjects with atopic asthma. 16 Therefore, the interaction between LPS exposure and genetic variants in the LPS response pathway may have different consequences depending on the stage of the disease at which exposure occurs. Indeed, recent data from a rat model confirm that early exposure to LPS suppresses allergic sensitization, but LPS administration to already sensitized animals exacerbates allergic inflammation. 17 At the cellular and molecular levels, the interplay between LPS-dependent signals, CD14 engagement and IgE regulation appears to be complex. We have previously shown that addition of LPS to peripheral blood mononuclear cells or B cell-enriched populations stimulated with exogenous IL-4 in vitro results in a striking up-regulation of IgE production. 18 On the other hand, we also showed that engagement of selected CD14 epitopes by anti-CD14 monoclonal antibodies inhibits IL-4-dependent human IgE synthesis. 19 Of note, anti-CD14 antibodies were still inhibitory for IgE when added after 6 days of culture, suggesting that inhibition targets a late B-cell activation event. Suppression of IgE synthesis following CD14 engagement did not result from a cytokine-mediated effect. Notably, CD14 engagement blocked IgE induction at the B-cell level, because inhibition was observed both in T-cell-dependent and T-cell-independent systems. 19 Thus, IL-4-dependent in vitro IgE synthesis is enhanced by bacterial CD14 ligands, but is inhibited by antibody-mediated CD14 engagement.
The opposite effects that different modalities of CD14 engagement have on IgE synthesis highlight the complexity of the role played by monocyte/macrophages in IgE regulation. The mechanisms underlying this discrepancy remain unclear. However, it should be pointed out that Bcells express molecule(s), unidentified to date, that bind a soluble CD14-IgG1 fusion protein and may correspond to functional CD14 ligand(s) and/or components of the LPS signaling pathway (Soprana and Vercelli, unpublished observations).
As a final touch to a remarkable complexity, we have previously shown that IL-4 and IL-13, the signals necessary to induce class switching to IgE, directly down-regulate the expression of both membrane-bound and sCD14 by acting at the transcriptional level. 20, 21 Downregulation of CD14 by Th2 cytokines may play an important role in maintaining the vicious circle triggered by allergic sensitization (see below, Fig. 2 ). 
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CONCLUSIONS
In conclusion, we propose that LPS, CD14 and Th differentiation may be part of a complex circuit that is triggered by different combinations of environmental stimuli and can either up-regulate or suppress IgE-dependent reactions. Allergens typically evoke adaptive responses that result in increased Th2 differentiation, enhanced IL-4/IL-13 expression and enhanced IgE production. Down-regulation of CD14, and consequently, reduced LPS-inducible expression of IL-12 and IL-18 (cytokines essential in promoting Th1 responses) may be a key step in allowing Th2 differentiation to proceed undisturbed (Fig. 2, left panel) . Conversely, presentation of the allergen by antigen presenting cells simultaneously stimulated by bacterial ligands would recruit innate immune pathways and, by enhancing CD14 expression and LPS responsiveness, would lead to increased expression of IL-12 and IL-18 and decreased Th2 differentiation. This in turn would result in suppression of IgE responses (Fig. 2, right panel) . Our current goal is to establish the molecular mechanisms through which polymorphisms in the regulatory region of CD14 affect the expression of this gene and its role in IgE regulation.
